AstraZeneca Net Profit Boosted by Licensing Deals – Wall Street Journal

AstraZeneca Net Profit Boosted by Licensing Deals
Wall Street Journal
LONDON—AstraZeneca PLC’s net profit increased in the fourth quarter, as a rise in mostly one-time proceeds from royalties and licensing deals helped offset a sharp fall in revenue from its biggest-selling drug. The Cambridge, England-based company

and more »

Read More…

Share This: